GlassScriptPhysician profile
Paul Blake Obrien
NPI 1821007220
$16,960.53
in general payments reported to CMS, 2019-2025
6 companies · $6,378 in 2025
The $6,378 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $113 · 2021: $114 · 2022: $4,074 · 2023: $6,145 · 2025: $6,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $1,090 · Food and Beverage: $612 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,800.00 |
| Travel and Lodging | $1,090.08 |
| Food and Beverage | $612.21 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $16,517.37 | 2021-2025 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $242.00 | 2019-2022 | |
| Chiesi USA, INC. | $113.38 | 2020 | |
| Mindray Ds USA, INC. | $41.64 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.14 | 2019-2021 | |
| Csl Behring | $20.00 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Blake Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.